Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
49,933.66
+2,580.16
(+5.45%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
Citius Pharmaceuticals, Inc. (CTXR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7050
-0.0020
(-0.28%)
At close: 04:00PM EDT
0.7100
+0.00
(+0.71%)
After hours:
06:52PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
13,996
14,820
17,655
12,241
8,813
Selling general and administrative
24,827
21,912
15,661
11,291
8,898
Total operating expenses
38,823
36,732
33,316
23,532
17,711
Operating income or loss
-38,823
-36,732
-33,316
-23,532
-17,711
Interest expense
-
-
0
10.839
15.673
Total other income/expenses net
-
3,586
-
226.474
110.207
Income before tax
-37,604
-31,967
-33,065
-23,054
-17,548
Income tax expense
576
576
576
0
0
Income from continuing operations
-38,180
-32,543
-33,641
-23,054
-17,548
Net income
-38,180
-32,543
-33,641
-23,054
-17,548
Net income available to common shareholders
-39,332
-33,694
-33,641
-24,505
-17,548
Basic EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Diluted EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Basic average shares
151,295
151,295
146,082
108,599
39,165
Diluted average shares
151,295
151,295
146,082
108,599
39,165
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.